Environmental, Social, and Governance (ESG)

As part of our commitment to society, our people and the environment, MMS completes a thorough assessment of its business sustainability practices every year through EcoVadis, a global leader in business sustainability assessments. The EcoVadis assessment includes 21 sustainability criteria across four core themes: Environment, Labor & Human Rights, Ethics and Sustainable Procurement.

In our latest rating, which was completed in September 2024, we earned a Bronze Medal which places MMS in the top 35% globally.

MMS discloses annual GHG emissions data to CDP, and in 2024 was awarded an SME Climate score grade B.

The Carbon Disclosure Project (CDP) is a global non-profit that runs the world’s only independent environmental disclosure system for companies, capital markets, cities, states and regions to manage their environmental impacts.

This data helps stakeholders, including investors, better understand and manage the financial risks associated with climate change and make informed investment decisions. The purpose of which is to facilitate a sustainable economy by encouraging environmental reporting and risk management, ultimately leading to more sustainable practices and a reduction in environmental impact.

In 2024 MMS also made a public commitment to The Science Based Targets Initiative (SBTi).

The Science Based Targets initiative (SBTi) is a global body enabling businesses to set ambitious emissions reduction targets in line with the latest climate science. The SBTi’s goal is to accelerate companies across the world to support the global economy to halve emissions before 2030 and achieve net-zero before 2050.

The initiative is a collaboration between CDP, the United Nations Global Compact, World Resources Institute (WRI) and the World Wide Fund for Nature (WWF) and one of the We Mean Business Coalition commitments. The SBTi defines and promotes best practice in science-based target setting, offers resources and guidance to reduce barriers to adoption, and independently assesses and approves companies’ targets.

Our success is intertwined with the well-being of the communities we serve and the experts that we employ. MMS fosters an inclusive and supportive workplace to drive positive change for individual stakeholders, partners, sponsors, and ultimately the public through the outcomes from our work.

This includes the following:

• Diversity, Equity, and Inclusion: MMS is committed to maintaining a diverse and inclusive environment where all employees feel valued and empowered to contribute their best. Our DEI initiatives are embedded in our recruitment, training, and continuous leadership development programs.
• Community Engagement: We actively engage with the local communities that we operate in, through individual and company-led volunteer efforts and other initiatives. Our team members are given time during the workday to volunteer and MMS provides resources to amplify their impact.
• Patient-Centric Outcomes: Our work with sponsors prioritizes patient safety, transparency, and accessibility. We strive to ensure that our support of drug development programs across nearly all therapeutic areas maintain high ethical and scientific standards, allowing the results to have a meaningful contribution to public health.

We are dedicated to minimizing the environmental footprint of MMS and promoting sustainable practices across all our operations around the world. We proactively seek to reduce energy consumption, manage waste responsibly, and support environmental initiatives internally and in the communities where we live and work.

By leveraging technology and data-driven solutions, we optimize our processes to ensure efficiency and sustainability, including:

• Green Facilities: We are committed to maintaining eco-friendly offices, implementing energy-saving methodologies and technologies, as well as reducing our reliance on non-renewable resources.
• Sustainable Operations: Through continuous monitoring and assessment, we identify areas where MMS colleagues can reduce waste, recycle materials, and minimize our impact on the environment.
• Collaborative Initiatives: We partner with like-minded organizations to advance environmental sustainability in clinical research, aiming for a higher standard.

We believe in having an inclusive procurement process that promotes equality and fairness. Our aim is to have a dynamic and diverse supply base providing equal opportunities for suppliers. We recognize that small and medium sized businesses (SMEs) and Diverse Businesses are a vital part of the economy, increasing employment opportunities and contributing to the wellbeing of the communities across our global locations.

In support of this, MMS will aim to invigorate our supply base (and supporting supply chain), to encourage new opportunities for diverse suppliers, specifically SMEs, to engage with MMS across all of our global locations.

Read our Supplier Diversity Statement.

MMS is guided by a strong governance framework that ensures clarity and accountability at all levels of the organization globally. Our governance practices are designed to protect the interests of our stakeholders, including:

• Ethical Standards: We adhere to the highest ethical standards across all projects and business practices. This ensures that all activities are conducted with integrity and respect for the regulatory requirements set by global health authorities.
• Transparent Reporting: We are committed to providing clear and accurate reporting on our ESG initiatives, demonstrating our progress and areas for improvement. This allows us to build further trust with our stakeholders and reinforce our commitment to accountability.
• Continuous Improvement: Our governance framework is dynamic, changing as pharmaceutical industry best practices evolve and stakeholder expectations heighten. We regularly review and enhance our policies and procedures to ensure they align with our ESG goals.

Read our full commitment:
Download MMS Human Rights and Modern Slavery Statement.